平台化

Search documents
极氪科技一季度财报亮眼:双品牌协同发力 盈利能力持续提升
Cai Jing Wang· 2025-05-20 07:28
扭亏为盈,极氪科技交出一份亮眼的财务成绩单。 5月15日,极氪科技发布2025年第一季度未经审计财务业绩,这也是极氪与领克并表后的首份季度财报。 数据显示,极氪科技一季度整车毛利率16.5%,同比上升3.4个百分点;综合毛利率攀升至19.1%,创历史最高。此外,净亏损大幅 收窄,同比降低超60%。今年一季度,极氪科技集团共交付114,011辆汽车,同比增长21.1%。 在《台州宣言》的指导下,极氪科技正加速推进平台化技术共享,盈利能力不断提升,规模化优势也初现成效。 盈利能力提升 双品牌均达成财务表现历史同期最好。 在香港会计准则下,极氪科技已经连续三个季度盈利,今年一季度实现盈利5.1亿元。 财报数据显示,极氪科技一季度总营收达220亿元。其中,整车销售收入191亿元,同比增长16.1%;一季度整车毛利率16.5%,同 比上升3.4个百分点;综合毛利率攀升至19.1%,创历史最高。净亏损大幅收窄,同比降低超60%。 图源:极氪官方 交付层面,今年一季度,极氪科技销量114,011台,整合后极氪科技单月销量持续突破4万台,规模化效应凸显。 极氪科技集团CEO安聪慧表示:"对两大品牌进行了初步技术整合、优化研发 ...
蜜雪冰城跨界精酿啤酒:千亿帝国的增长焦虑与供应链野望
Xin Lang Zheng Quan· 2025-05-20 02:30
2025年3月3日,蜜雪冰城以43.21%的涨幅登陆港交所,市值突破千亿港元,成为全球现制饮品行业的 市值冠军。然而,这家以"极致性价比"横扫下沉市场的巨头,上市2个月后突然宣布跨界精酿啤酒领 域,引发资本市场热议。这一动作背后,既有其供应链能力的外溢野心,也折射出新茶饮行业增速放缓 下的增长焦虑。 从"4元柠檬水"到精酿啤酒:蜜雪冰城的跨界逻辑与战略动因 目前,蜜雪冰城的核心业务已接近国内市场天花板。截至2024年12月,其全球门店数量达4.65万家,超 越星巴克成为全球最大现制饮品企业,其中57.4%的门店位于三线及以下城市。然而,下沉市场的门店 密度已接近饱和——按人口测算,中国三线及以下城市门店上限约为6-8万家。与此同时,单店日均终 端零售额从2023年前三季度的4416.3元降至2024年前三季度的4184.4元,显示存量市场竞争加剧。 在此背景下,蜜雪冰城亟需寻找第二增长曲线。精酿啤酒作为近年来年均增速超20%的高潜力市场,与 其现有客群(价格敏感型消费者)存在重叠,且供应链协同空间显著。通过低价策略(如定价8-12元/ 瓶),蜜雪冰城可复用其"高质平价"基因,抢占传统啤酒巨头与高端精酿品牌之间 ...
砥砺十载,扬帆新程 | 先导智能举办上市十周年庆典活动!
Jing Ji Guan Cha Wang· 2025-05-19 11:29
2015年5月18日,先导智能成功登陆创业板,正式迈入资本市场。十年间,公司始终聚焦"新能源+高端装备"黄金赛道,坚定不移推进"全球化+平台化"双轮 驱动战略,业务版图从锂电设备拓展至光伏、3C、智能物流、汽车智能产线、氢能等多个领域,为客户提供涵盖"核心装备+整线集成+智能制造+智慧服 务"的全方位解决方案体系,持续赋能全球产业升级。 根据国际权威机构弗若斯特沙利文数据,以2024年订单价值计算,先导智能蝉联全球新能源智能装备及解决方案提供商榜首地位,市场份额较2023年提升 3.3个百分点,持续巩固行业龙头优势。目前,先导智能的产品与服务已覆盖全球24个国家,在海外设立18家分子公司,品牌影响力不断提升。 在快速发展的同时,先导智能始终坚守合规经营底线,连续六年获深交所信息披露A级评级,位列标普全球机械行业可持续发展评估前15%,并荣膺"上市公 司金牛奖"等多项荣誉,以高质量治理赢得资本市场长期信任。公司坚持以投资者为本的理念,2020年以来每年现金分红总额占当年归母净利润比例均超 30%,持续与股东共享发展成果。 登录新浪财经APP 搜索【信披】查看更多考评等级 2025年5月19日,作为全球领先的新能 ...
雷赛智能20250518
2025-05-18 15:48
雷赛智能 20250518 摘要 • 雷赛智能通过运动平台化建设,助力人形机器人产业链发展,尤其在手眼 脑协同领域取得显著进展,从躯干下半身逐步落地到手臂一体化及视觉反 馈,实现小脑协同,技术在国内零部件公司中领先。 • 公司经历了三次创业,从技术驱动到资本赋能,再到智能化转型与战略突 破。上市后迎来爆发式增长,推出多种新产品,并切入人形机器人核心零 部件领域。 • 雷赛智能重视研发投入,研发人员占比超过三分之一,研发投入占比超过 12%,主要研发负责人具有资深背景和十年以上经验,确保技术领先。 • 公司发布股权激励和员工持股计划,覆盖大量员工,显示出激励力度大且 覆盖面广,有助于增强员工积极性并提升公司发展信心。 • 通过持续拓品类和扩渠道,公司运控平台化逐渐成型,伺服系统已进入国 产头部序列。经销占比快速提升至接近一半,有望拉动工作效率及利润率 提升。 • 尽管大环境不佳,公司收入端仍维持正增长。2024 年收入上升 12%,利 润上升超过 40%。毛利率接近 39%,净利率 13%,控制类技术毛利率稳 定在 65%以上。 • 伺服系统占比持续提升,2024 年已占公司收入 45%,成为第一大收入来 源。 ...
奥特维(688516):2024年营收高增,2025年加快海外市场拓展及新品研发
Changjiang Securities· 2025-05-17 15:01
丨证券研究报告丨 联合研究丨公司点评丨奥特维(688516.SH) [Table_Title] 奥特维:2024 年营收高增,2025 年加快海外市 场拓展及新品研发 报告要点 [Table_Summary] 公司发布 2024 年年报及 2025 年一季度报告,公司 2024 年营收实现高增,但 2024Q4 开始行 业整体经营压力有所体现。公司新接订单同比下降,但公司积极拓展海外市场,24 年实现海外 收入 15.31 亿元,同比+53.43%。公司将加快海外市场拓展步伐,形成收入增量。同时,由于 产品验收结构变化,公司盈利能力表现承压,但控费能力依然较强。公司继续夯实平台化业务 发展,对公司市场长期竞争力和盈利修复保有信心。 分析师及联系人 [Table_Author] 赵智勇 邬博华 曹海花 倪蕤 刘晓舟 SAC:S0490517110001 SAC:S0490514040001 SAC:S0490522030001 SAC:S0490520030003 SAC:S0490524030001 SFC:BRP550 SFC:BQK482 请阅读最后评级说明和重要声明 %% %% %% %% [Table ...
极氪科技发布一季度财报:营收220亿元,综合毛利率19.1%
Xin Lang Ke Ji· 2025-05-15 04:57
交付层面,一季度,极氪科技销量114,011台,位居中国新势力高端豪华销量第一。尤其整合以来,极 氪科技单月销量持续突破4万台,规模化效应显著。极氪品牌和领克品牌持续推进平台化技术共享,一 季度研发投入29亿元。据悉,下半年,极氪品牌将有两款、领克品牌将有一款全新车型推向市场,助推 销量增长。 产品方面,极氪向上、领克向宽。极氪科技双品牌差异化布局,覆盖15万-90万元价格带的全场景产品 市场。极氪品牌深耕30万元以上豪华市场,极氪007GT上市首月实现万台下线交付,极氪009光辉典藏 版进一步布局超豪华市场,极氪9X在上海车展首秀,将于今年三季度上市发布;领克品牌主攻20万元 及以上市场,小型车聚焦纯电,中大型车聚焦混动。领克900自4月28日上市以来,大定量已超3万+。 为响应《台州宣言》并深化落地,极氪科技有序推进整车架构、电子电气架构、三电、智能辅助驾驶、 智舱等关键平台技术的资源整合与共享。吉利智能辅助驾驶3月初推出了统一的智能辅助驾驶解决方 案"千里浩瀚",极氪品牌后续新品都将搭载千里浩瀚H7、H9方案;智能座舱方面,极氪领克将在域控 制器、电子架构层面进行共享,同时保留LYNK Flyme Au ...
从99%到99.99%,Robotaxi正在跨越“最后一公里”?
美股研究社· 2025-05-14 10:28
来源 | 美股研究社 作者丨江河有堤 2025年,或许注定是自动驾驶与人工智能深度融合的爆发年。 此前,特斯拉宣布将于6月在美国得克萨斯州奥斯汀推出"完全无人监督"的Robotaxi服务,并计 划2026年量产无方向盘车型CyberCab。 不仅如此,马斯克旗下AI公司xAI完成60亿美元融资,剑指算力超级工厂,试图为特斯拉的自动 驾驶技术注入新动能。 全球网约车巨头优步(Uber)与Lyft则通过合作Waymo、Mobileye加速自动驾驶商业化,此外, 两大巨头于近日先后交出一季报,自动驾驶业务均取得进展显著。中国玩家小马智行、文远知行 也不甘落后,与联手优步将Robotaxi服务拓展至中东与欧洲市场。 技术与资本的狂潮下,Robotaxi与AI的融合正成为新能源汽车产业争夺的制高点,一场万亿级市 场的全球竞速已然展开。 技 术 竞 速 进 行 时 A I 算 力 与 数 据 闭 环 的 " 护 城 河 " 之 争 Robotaxi市场上,最大的热门之一——特斯拉已经与xAI形成"软硬合围"之势。现阶段来看,其 核心竞争力就来自其全自动驾驶(FSD)系统的数据积累与AI算力支持。 相关数据显示,特斯拉FS ...
Q1归母扣非净利润暴增194.14%,平台化加速推进的盛美上海(688082.SH)有望迎“戴维斯双击”
智通财经网· 2025-05-13 00:47
Core Viewpoint - Shengmei Shanghai (688082.SH) demonstrates strong growth momentum driven by its core strategies of "technological differentiation, product platformization, and global customer base," as evidenced by its impressive Q1 2025 financial results [1][14]. Financial Performance - In Q1 2025, Shengmei Shanghai reported revenue of 1.306 billion yuan, a year-on-year increase of 41.73%, and a net profit attributable to shareholders of 246 million yuan, a staggering year-on-year growth of 207.21% [1]. - The company's net profit after deducting non-recurring items reached 248 million yuan, reflecting a year-on-year increase of 194.14% [1]. - The revenue and net profit figures represent historical highs for the company in the same quarter [1]. Market Outlook - UBS forecasts Shengmei Shanghai's revenue to reach 7.05 billion yuan in 2025, with a compound annual growth rate of over 20% expected from 2025 to 2027 [2]. - The company has built strong competitive barriers, and the Q1 2025 results are seen as the beginning of accelerated performance release, with expectations of entering a new high-growth phase [2]. Order Backlog and Cash Flow - Shengmei Shanghai's contract liabilities totaled 1.228 billion yuan, a year-on-year increase of 31.13%, indicating a robust order backlog [4]. - The net cash flow from operating activities improved significantly to 93 million yuan, compared to a cash outflow of 155 million yuan in the same period last year [4]. Industry Context - The global semiconductor equipment market is expected to recover, with a projected market size of 113 billion USD in 2024, growing by 6.4% year-on-year [6]. - China is the largest semiconductor equipment market, with a compound annual growth rate exceeding 20% from 2020 to 2024, significantly outpacing global growth [9]. Product Diversification and Platform Development - Shengmei Shanghai has successfully developed a diverse product portfolio, including cleaning equipment, electroplating equipment, and various semiconductor process equipment, positioning itself as a leading platform enterprise in the industry [10]. - The company has achieved significant market shares in cleaning and electroplating equipment, with international market shares of 8% and 8.2%, respectively [10]. - The company is expanding its product offerings and has begun mass production of several new technologies, including advanced packaging electroplating equipment and atomic layer deposition (ALD) systems [11][12]. Future Growth Potential - Shengmei Shanghai's platform development is expected to accelerate, with new products projected to become significant revenue contributors in the next two to three years [12]. - The company is poised for continued high growth as it capitalizes on the recovery of the semiconductor industry and its strong order backlog [14].
工银瑞信基金董事长赵桂才:提高权益投资规模及稳定性,为投资者创造更优长期回报
Cai Jing Wang· 2025-05-09 14:40
Core Viewpoint - The release of the "Action Plan for Promoting High-Quality Development of Public Funds" by the China Securities Regulatory Commission (CSRC) is a significant measure to implement the decisions of the Party Central Committee and serves as a guide for the high-quality development of public funds [1][2] Policy Deployment and Direction - The "Action Plan" outlines the overall thinking, basic principles, and goals for high-quality development of public funds, proposing 25 policy measures across six areas, including optimizing fund operation models and enhancing regulatory enforcement [2] - The focus of the reform is on strengthening the alignment of interests with investors, enhancing the stability of fund investment behavior, and promoting the growth of equity funds [2][3] Emphasis on Equity Investment - The key point for high-quality development of public funds is to enhance equity investment, increase its scale and stability, and better serve national strategies and the development of the real economy [3][4] Building a Platform-Based Research System - The "Action Plan" emphasizes the construction of a "platform-based, integrated, multi-strategy" research system to enhance the professional asset management capabilities of fund companies [4] - Talent development and technological advancements are crucial for improving research capabilities and ensuring sustainable competitiveness in the industry [4] Long-Term Value Investment - The "Action Plan" mandates that public funds adhere to long-term and value investment principles, prohibiting style drift and reducing turnover rates, thus addressing industry issues of prioritizing scale over returns [5] - The current valuation of the A-share market, with a rolling P/E ratio of 12.3, indicates significant long-term investment appeal [5] Encouraging Equity Fund Development - The "Action Plan" encourages innovation in equity fund products, particularly floating fee structures and index products, to enhance investor engagement and align interests [6] - Strengthening the supply of equity fund products and improving investment management are key focuses for fund companies [6] Enhancing Investor Service Capabilities - The "Action Plan" calls for improved service levels for investors, shifting the focus from scale to returns, and establishing a classification evaluation mechanism for fund sales institutions [7] - Fund companies are encouraged to enhance asset management capabilities and align product offerings with investor needs [7] Building First-Class Investment Institutions - The "Action Plan" emphasizes the need for public fund companies to build first-class investment institutions by enhancing governance, core research capabilities, and compliance management [9] - As a state-owned bank-controlled fund company, the firm aims to implement the "Action Plan" requirements and contribute to the high-quality development of the public fund industry [9]
可孚医疗(301087):核心产品稳健增长,健耳短期利润承压
Hua Yuan Zheng Quan· 2025-05-09 13:43
Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The company's core products are experiencing steady growth, while short-term profits are under pressure due to the performance of the hearing aid segment [5][7] - The company is expected to focus on core products and self-manufactured items, with a rich product pipeline that is likely to enhance profitability in the future [7] Financial Performance Summary - For 2023, the company reported revenue of 2,854 million RMB, with a year-on-year decline of 4.14%. The net profit attributable to the parent company was 254 million RMB, down 15.71% year-on-year [6] - Revenue is projected to grow to 3,495 million RMB in 2025, representing a year-on-year increase of 17.15%. The net profit is expected to reach 376 million RMB, with a growth rate of 20.45% [6][8] - The gross margin for 2024 is reported at 51.9%, an increase of 8.6 percentage points year-on-year, with significant improvements in the rehabilitation aids segment [7] Business Segment Performance - The rehabilitation aids segment achieved revenue of 1.1 billion RMB, up 42.8% year-on-year. The traditional Chinese medicine therapy and other segments generated 180 million RMB, up 20.5% year-on-year [7] - The hearing aid segment reported revenue of 270 million RMB, a year-on-year increase of 37.9%, but also faced a net loss of 43.25 million RMB due to a challenging consumer environment and new store performance [7] Profitability and Valuation - The company is expected to see net profits of 3.8 billion RMB, 4.5 billion RMB, and 5.4 billion RMB from 2025 to 2027, with growth rates of 20.4%, 20.2%, and 20.6% respectively [7] - The current price-to-earnings (P/E) ratios for 2025, 2026, and 2027 are projected to be 19X, 16X, and 13X respectively [7]